By Michele Maatouk
Date: Tuesday 16 May 2023
(Sharecast News) - Horizon Therapeutics tumbled in pre-market trade on Tuesday following a report that its $27.8bn takeover by Amgen will be challenged by federal regulators.
No recent information was found.
| Currency | US Dollars |
| Share Price | $ 0.00 |
| Closing Price Change | $ 0.00 |
| % Change | 0.00 % |
| 52 Week High | $0.00 |
| 52 Week Low | $0.00 |
| Volume | 0 |
| Shares Issued | 184.43m |
| RiskGrade | 250 |
You are here: research